ELIZABETH BANKERT: Open Payments
NPI 1992014187 · SILVER SPRING, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,063 in 47 payments from 17 companies in 2025. Trend: 2023 $1,155 · 2024 $1,214 · 2025 $1,063
Food & beverage: $1,063
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 9 | $160 |
| Biogen, Inc. | 8 | $152 |
| Lundbeck LLC | 4 | $108 |
| ABBVIE INC. | 4 | $91 |
| Teva Pharmaceuticals USA, Inc. | 3 | $81 |
| Lilly USA, LLC | 3 | $79 |
| Eisai Inc. | 2 | $66 |
| Neurocrine BioSciences, Inc. | 2 | $58 |
| Axsome Therapeutics, Inc. | 2 | $57 |
| Amneal Pharmaceuticals LLC | 2 | $54 |
Products named: NURTEC ODT, TYSABRI, AUSTEDO XR, AMYVID, VYEPTI, Leqembi, INGREZZA, Symbravo.
Industry payments across MD — which companies pay providers there.
